| Literature DB >> 35096794 |
Zhishuai Chang1, Wei Dai1, Yufeng Mao1,2, Zhenzhen Cui1, Zhidan Zhang2, Zhiwen Wang1, Hongwu Ma2, Tao Chen1.
Abstract
Acetate is an economical and environmental-friendly alternative carbon source. Herein, the potential of harnessing Corynebacterium glutamicum as a host to produce 3-hydroxypropionic acid (3-HP) from acetate was explored. First, the expression level of malonyl-CoA reductase from Chloroflexus aurantiacus was optimized through several strategies, strain Cgz2/sod-N-C* showed an MCR enzyme activity of 63 nmol/mg/min and a 3-HP titer of 0.66 g/L in flasks. Next, the expression of citrate synthase in Cgz2/sod-N-C* was weakened to reduce the acetyl-CoA consumption in the TCA cycle, and the resulting strain Cgz12/sod-N-C* produced 2.39 g/L 3-HP from 9.32 g/L acetate. However, the subsequent deregulation of the expression of acetyl-CoA carboxylase genes in Cgz12/sod-N-C* resulted in an increased accumulation of intracellular fatty acids, instead of 3-HP. Accordingly, cerulenin was used to inhibit fatty acid synthesis in Cgz14/sod-N-C*, and its 3-HP titer was further increased to 4.26 g/L, with a yield of 0.50 g 3-HP/g-acetate. Finally, the engineered strain accumulated 17.1 g/L 3-HP in a bioreactor without cerulenin addition, representing the highest titer achieved using acetate as substrate. The results demonstrated that Corynebacterium glutamicum is a promising host for 3-HP production from acetate.Entities:
Keywords: 3-hydroxypropionic acid; Corynebacterium glutamicum; acetate; fed-batch fermentation; malonyl-CoA pathway; metabolic engineering; metabolomics analysis
Year: 2022 PMID: 35096794 PMCID: PMC8790568 DOI: 10.3389/fbioe.2021.808258
Source DB: PubMed Journal: Front Bioeng Biotechnol ISSN: 2296-4185
3-HP titers and yields of different substrates.
| Organism | Carbon source | Operational technique | Titer (g/L) | Yield (g/g) | References |
|---|---|---|---|---|---|
|
| Glucose | Fed-batch, 5-L bioreactor | 62.6 | 0.51 |
|
|
| Glycerol | Fed-batch, 5-L bioreactor | 102.6 | - |
|
|
| Acetate | Whole-cell biocatalysis | 15.8 | 0.71 |
|
|
| Acetate | Fed-batch, 5-L bioreactor | 17.1 | 0.10 | This study |
|
| 1,3-Propanediol | Fed-batch, 7-L bioreactor | 154 | 0.93 |
|
|
| Fatty acids | Fed-batch, 5-L bioreactor | 52 | 1.56 |
|
Engineered microorganisms.
FIGURE 1Schematic diagram of 3-HP biosynthetic route in Corynebacterium glutamicum via acetate assimilation. Black arrows indicate the native pathways of C. glutamicum, red arrows indicate genes which were overexpressed or introduced, green arrows indicate genes which were weakened, and dotted arrows indicate genes which were deleted. Acetyl-P, acetyl phosphate; 3-HP, 3-hydroxypropionic acid; ldhA, lactate dehydrogenase; ackA, acetate kinase A; pta, acetyl phosphate transferase; acc, acetyl-CoA carboxylase; mcr-C, C-terminal of malonyl-CoA reductase; mcr-N, N-terminal of malonyl-CoA reductase; fasA, fatty acid synthetase A; fasB, fatty acid synthetase B; fasR, fatty acid repressor; gltA, citrate synthase.
Bacterial strains and plasmids used in this study.
| Strains and plasmids | Description | Source |
|---|---|---|
| Strains | ||
| | Host for plasmid construction | Invitrogen |
| ATCC 13032 |
| ATCC |
| Cgz2 | ATCC 13032 Δ |
|
| Cgz8 | Cgz2 P1- | This study |
| Cgz9 | Cgz2 P5 | This study |
| Cgz10 | Cgz2 P7- | This study |
| Cgz11 | Cgz8 with the replacement of | This study |
| Cgz12 | Cgz8 with the replacement of | This study |
| Cgz13 | Cgz2 with mutated | This study |
| Cgz14 | Cgz12 with mutated | This study |
| Cgz2/ | Cgz2 harboring plasmid pEC- | This study |
| Cgz2/ | Cgz2 harboring plasmid pEC- | This study |
| Cgz2/mbp- | Cgz2 harboring plasmid pEC-mbp- | This study |
| Cgz2/his- | Cgz2 harboring plasmid pEC-his- | This study |
| Cgz2/N-C | Cgz2 harboring plasmid pEC-N-C | This study |
| Cgz2/N-C* | Cgz2 harboring plasmid pEC-N-C* | This study |
| Cgz2/C*-N | Cgz2 harboring plasmid pEC-C*-N | This study |
| Cgz2/H36-N-C* | Cgz2 harboring plasmid pEC-H36-N-C* | This study |
| Cgz2/sod-N-C* | Cgz2 harboring plasmid pEC-sod-N-C* | This study |
| Cgz2/sod-mbp-N-C* | Cgz2 harboring plasmid pEC-sod-mbp-N-C* | This study |
| Cgz8/sod-N-C* | Cgz8 harboring plasmid pEC-sod-N-C* | This study |
| Cgz9/sod-N-C* | Cgz9 harboring plasmid pEC-sod-N-C* | This study |
| Cgz10/sod-N-C* | Cgz10 harboring plasmid pEC-sod-N-C* | This study |
| Cgz11/sod-N-C* | Cgz11 harboring plasmid pEC-sod-N-C* | This study |
| Cgz12/sod-N-C* | Cgz12 harboring plasmid pEC-sod-N-C* | This study |
| Cgz13/sod-N-C* | Cgz13 harboring plasmid pEC-sod-N-C* | This study |
| Cgz14/sod-N-C* | Cgz14 harboring plasmid pEC-sod-N-C* | This study |
| Plasmids | ||
| pEC-XK99E | KanR
|
|
| pEC- | KanR, pEC-XK99E containing gene | This study |
| pEC- | KanR, pEC-XK99E containing mutated gene | This study |
| pEC-mbp- | KanR, pEC- | This study |
| pEC-his- | KanR, pEC- | This study |
| pEC-N-C | KanR, pEC-XK99E containing separated | This study |
| pEC-N-C* | KanR, pEC-N-C with mutated | This study |
| pEC-C*-N | KanR, pEC-N-C* with the order of | This study |
| pEC-H36-N-C* | KanR, pEC-N-C* with Ptrc substituted by PH36 | This study |
| pEC-sod-N-C* | KanR, pEC-N-C* with Ptrc substituted by Psod | This study |
| pEC-sod-mbp-N-C* | KanR, pEC-sod-N-C* with mbp tag sequence inserted between promoter and RBS | This study |
| pEC-mbp-N-C* | KanR, pEC-N-C* with mbp tag sequence inserted between promoter and RBS | This study |
| pD- | KanR, vector for in-frame deletion |
|
| pD- | pD- | This study |
| pD- | pD- | This study |
| pD- | pD- | This study |
| pD- | pD- | This study |
| pD- | pD- | This study |
| pD- | pD- | This study |
| pD- | pD- | This study |
American Type Culture Collection.
Kanamycin resistance.
FIGURE 2Overviews of a series of mcr overexpression plasmids and their applications in 3-HP production. (A) Schematic drawing of different mcr overexpression plasmids, and their respective MCR enzyme activities. (B) 3-HP concentrations of Cgz2 series strains.
FIGURE 3Characterizations of citrate synthase (CS) modified recombinant strains. (A) 3-HP production, (B) cell growth (OD600), (C) acetate consumption, and (D) CS enzyme activities.
FIGURE 4Effect delineations of deregulation of acc. Time profiles of cell growth (OD600), acetate, and 3-HP concentrations of recombinant strains Cgz2/sod-N-C* and Cgz13/sod-N-C*. Circles indicate strain Cgz2/sod-N-C*. Triangles indicate strain Cgz13/sod-N-C*.
FIGURE 5Changes of intracellular metabolites in response to different genetic manipulations. (A) Heat map (log2 fold change) showing the changes of intracellular metabolites involving central carbon metabolism in strains Cgz2/sod-N-C*, Cgz12/sod-N-C*, Cgz13/sod-N-C*, and Cgz14/sod-N-C* at 12 h. “#” indicates metabolites that could not be distinguished in LC-MS. Comparison of intracellular (B) relative NADH content and NADH/NAD+ ratio, and (C) relative NADPH content and NADPH/NADP+ ratio in strains Cgz2/sod-N-C*, Cgz12/sod-N-C*, Cgz13/sod-N-C*, and Cgz14/sod-N-C* at 12 h. (D) Time profile of cell growth (OD600), acetate, and 3-HP concentrations of Cgz12/sod-N-C* and Cgz14/sod-N-C* with addition of 15 μM cerulenin at 12 h.
FIGURE 6Time profiles of cell growth (OD600), acetate, and 3-HP concentrations during the fed-batch culture of recombinant strain Cgz14/sod-N-C* in a 5-L bioreactor. Pure acetate was added automatically into the broth to maintain pH at 7.0; 14 g sodium acetate was added externally at 96, 108, and 120 h.